Geninus announces interim results of preclinical ‘anti-cancer vaccine’ at the European Association for Cancer Research
Geninus (CEO Park Woong-yang) announced on the 9th that it will present the interim results of the pre-clinical test of the anti-cancer vaccine currently under development at the European Association for Cancer Research this year (EACR 2023). Founded in 1968, EACR is an academic society with more than 12,000 researchers from industry, academia and medicine […]